The 24 references in paper A. Rekstin R., J. Desheva A., X. Lu , G. Alexandrova I., A. Klimov I., J. Katz M., L. Rudenko G., А. Рекстин Р., Ю. Дешева А., Х. Лу, Г. Александрова И., А. Климов И., Д. Кац М., Л. Руденко Г. (2014) “ГЕТЕРОСУБТИПИЧЕСКИЙ ИММУННЫЙ ОТВЕТ И ЗАЩИТА ОТ ВЫСОКОПАТОГЕННОГО ВИРУСА ГРИППА А (H5N1) У МЫШЕЙ, ИММУНИЗИРОВАННЫХ ХОЛОДОАДАПТИРОВАННЫМ ВИРУСОМ ГРИППА А/ЛЕНИНГРАД/134/17/57(H2N2) // HETEROSUBTYPIC IMMUNE RESPONSE AND CROSS-PROTECTION AGAINST A HIGHLY PATHOGENIC A (H5N1) INFLUENZA VIRUS IN MICE IMMUNIZED WITH COLD-ADAPTED A/LENINGRAD/134/17/57 (H2N2) INFLUENZA VIRUS” / spz:neicon:mimmun:y:2005:i:6:p:503-510

1
Александрова Г.И., Климов А.И. Живая вакци$ на против гриппа.$ СПб, Наука, 1994.$ 151с.
(check this in PDF content)
2
Belshe R.B., Mendelman P.M. Safety and efficacy of live attenuated, cold$adapted, influenza vaccine – trivalent// Immunol. Allergy Clin. North Am. – 2003. $ Vol. 23.$ P. 745$767.
(check this in PDF content)
3
Epstein S.L., Lo C., Misplon J.A., Lawson C.M., Hendrickson B.A., Max E.E., Subbarao K. Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell depleted, β2$ microglobulin$deficient, and J chain$deficient mice// J.Immunol. – 1997. $ Vol.158. $ P.1222$1230.
(check this in PDF content)
4
Desheva J.A., Rudenko L.G., Alexandrova G.I., Lu X., Rekstin A.R., Katz J.M., Cox N.J., Klimov A.I. Reas$ sortment between avian apathogenic and human atten$ uated cold$adapted viruses as an approach for prepar$ ing influenza pandemic vaccines// Options for the Con$ trol of Influenza V/ International Congress Series 1263/ ed. Kawaoka Y. $ 2004. $ P.724$727.
(check this in PDF content)
5
Katz J.M., Lu X., Young S.A., Galphin J.C. Adju$ vant activity of the heat$labile enterotoxin from entero$ toxigenic Escherichia coli for oral administration of in$ activated influenza virus vaccine// J.Infect.Dis. $ 1997. $ Vol.175. $ P.352$363.
(check this in PDF content)
6
Kendal A.P., Skehel J.J., Pereira M.S. Concepts and procedures for laboratory based influenza surveil$ lance/ ed. US Public Health Service, Atlanta, CDC. $ 1982. $ P.B17$35.
(check this in PDF content)
7
Li S., Liu C., Klimov A., Subbarao K., Perdue M.L., Mo D., Ji Y., Woods L., Hietala S., Bryant M. Recombi$ nant influenza A virus vaccines for the pandemic hu$ man A/Hong Kong/97 (H5N1) viruses// J.Infec.Dis. – 1999. $ Vol.179. – P. 1132$1138.
(check this in PDF content)
8
Liang S, Mozdzanowska K., Pallandino G., Ger$ hard W. Heterosubtypic immunity to influenza type A virus in mice// J.Immunol. $1994. $Vol.152.$ P.1653$ 1661.
(check this in PDF content)
9
Lu X., Tumpey T.M., Morken T., Zaki S.R., Katz J.M. A mouse model for the evaluation of pathogenesis and immunity to influenza A(H5N1) viruses isolated from humans// J.Virol.$1999.$ Vol.73.$ P.5903$5911.
(check this in PDF content)
10
Nguyen H.H., Moldoveanu Z., Novak M.J. van Ginkel F.W., Ban E., Kiyono H., McGee J.R., Mestecky J. Heterosubypic immunity to lethal influ$ enza A virus infection is associated with virus$specif$ ic CD8+ cytotoxic T lymphocyte responses induced in mucosa$associated tissues// Virology. – 1999. $ Vol. 254. $ P.50$60.
(check this in PDF content)
11
Nicholson K.G., Colegate A.E., Podda A., Stephenson I., Wood J., Ypma E., Zambon M.C. Safety and antigenicity of non$adjuvanted and MF59$adju$ vanted influenza A/Duck/Singapore/97 (H5N3) vac$ cine: a randomized trial of two potential vaccines against H5N1 influenza// Lancet. $ 2001.$ Vol. 357.$ P.1937$ 1943.
(check this in PDF content)
12
Reed L.J., Munch H.A. A simple method of esti$ mating fifty percent endpoints// Am.J.Hyg. –1938. $ Vol.27. $ P.493$497.
(check this in PDF content)
13
Rowe T., Aberharthy A.A., Hu$Primmer J., Th$ ompson W.W., Lu X.H., Lim W., Fukuda K., Cox N.J., Katz J.M. Detection of antibody to avian influenza A(H5N1) virus in human serum by using a combina$ tion of serologic assays// J.Clin.Microbiol. – 1999. – Vol. 37. – P. 937$943.
(check this in PDF content)
14
Rudenko L.G., Arden N.H., Grigorieva E., Naychin A., Rekstin A., Klimov A.I., Donina S., Deshe$ va J., Holman R.C., DeGuzman A.,Cox N.J., Katz J.D. Immunogenicity and efficacy of Russian live attenuat$ ed and U.S. inactivated influenza vaccines used alone and in combination in nursing home residents//Vac$ cine.$ 2001.$ Vol.19.$ P.308$318.
(check this in PDF content)
15
Rudenko L.G., Lonskaya N.I., Klimov A.I., Va$ silieva R.I., Ramirez A. Clinical and epidemiological evaluation of live, cold$adapted influenza vaccine for 3$14 –years$olds// Bull.WHO. $ 1996. $ Vol.74.$ P.77$84.
(check this in PDF content)
16
Schulman J.L., Kilbourne E.D. Induction of par$ tial specific heterotypic immunity in mice by a single infection with influenza A virus// J.Bacteriol. $ 1965. $ Vol.89. $P.170.
(check this in PDF content)
17
Subbarao K., Chen H., Swayne D., Mingay L., Fodor E., Brownlee G., Xu X., Lu.X., Katz J., Cox N., Matsuoka Y. Evaluation of a genetically modified reas$ sortant H5N1 influenza A virus vaccine candidate gen$ erated by plasmid$based reverse genetics// Virology.$ 2003.$ Vol.305.$ P. 192$200.
(check this in PDF content)
18
Takada A., Kuboki N., Okazaki K., Ninomiya A., Tanaka H., Itamura S., Nishimura H., Enami M., Tashiro M., Shortridge K.F., Kida H. Avirulent avi$ an influenza virus as vaccine strain against a poten$ tial human pandemic// J.Virol. – 1999. $ Vol. 73. $ P.8303$8307.
(check this in PDF content)
19
Takada A., Matsushita S., Ninomiya A., Kawao$ ka Y., Kida H. Intranasal immunization with formalin$ inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus in$ fection in mice//Vaccine. $ 2003. $ Vol.21. $ P.3212$ 3218.
(check this in PDF content)
20
Tumpey T.M., Renshaw M., Clements J.D., Katz J.M. Mucosal delivery of inactivated influenza vaccine induces B$cell$dependent heterosubtypic cross$protec$ tion against lethal influenza A H5N1 virus infection// J.Virol. – 2001. $ Vol.75. $ P.5141$5150.
(check this in PDF content)
21
Webby R.J., Webster R.G. Are we ready for pan$ demic influenza?// Science.$ 2004.$ Vol.302.$ P.1519$ 1522.
(check this in PDF content)
22
Webby R.J., Perez D.R., Coleman J.S., Guan Y., Knight J.H., Govorkova E.A., McClain$Moss L.R., Peiris J.S., Rehg J.E., Tuomanen E.I., Web$ ster R.G. Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influ$ enza vaccines// Lancet.$ 2004.$ Vol. 363.$ P.1099$ 1103.
(check this in PDF content)
23
Webster R.G., Askonas B.A. Cross$protection and cross$reactive cytotoxic T cells induced by influen$ Рекстин А.Р., Дешева Ю.А. и др. za virus vaccines in mice // Eur.J.Immunol. $ 1980.$ Vol.10. $P.396$401.
(check this in PDF content)
24
Yap K.L., Ada G.L. The recovery of mice from influenza A virus infection: adoptive transfer of immu$ nity with influenza virus$specific cytotoxic T lympho$ cytes recognizing a common virion antigen // Scand. J.Immunol.$ 1978.$ Vol.8.$ P.413$420.
(check this in PDF content)